Women’s Racing Rocked by Doping Case as Italian Cyclist Tests Positive

Italian rider Linda Laporta has been provisionally suspended after testing positive for ostarine during the UAE Tour Women in February. The 22-year-old, who rides for the Italian national team, now faces a potential ban following the anti-doping violation, marking a rare and unwelcome development in the women's professional peloton. The UCI confirmed the adverse analytical finding, with proceedings now underway.

This incident is particularly notable given the relatively clean record of women's cycling compared to its male counterpart, especially concerning performance-enhancing drugs like ostarine, a selective androgen receptor modulator (SARM). While male cycling has grappled with numerous high-profile doping scandals, the women's peloton has largely avoided such widespread issues, making Laporta's case a stark reminder that vigilance remains paramount across all levels of the sport.

Laporta's misstep serves as a sobering, if isolated, reminder that the temptations of illicit enhancement are not gender-specific, nor are they confined to the sport's highest echelons. It's a shame, but not entirely unexpected.